简介：

简介：

简介：

简介：Themechanismsfortheregulationofsynapticdopamine(DA)includeitsreleasefrompresynapticvesicles,itsinteractionwithpost-synapticandpre-synapticDAreceptors,thereuptakeofDA,viadopaminetransporter(DAT),thediffusionofDAanditsmetabolismbymono-amineoxidase(MAO)andcatechol-O-methyltransferase(COMT).DAcontrolscomplexand

简介：AbstractBackground:Concerns exist regarding the risk of infections in patients with spondyloarthritis (SpA) treated with biologics. We assessed the risk of infections of biological and targeted drugs in patients with SpA by performing a meta-analysis based on randomized controlled trials (RCTs).Methods:A systematic literature search was conducted in PubMed, Embase, Web of Science, the Cochrane Library, and China Biology Medicine Disc for RCTs evaluating the risk of infections of biological therapy in patients with SpA from inception through August 9, 2021. We calculated a pooled Peto odds ratio (OR) for infections in biologics-treated patients vs. placebo patients. The risk of bias on the included RCTs was assessed by using the Cochrane Risk of Bias Tool.Results:In total, 62 studies were included in this meta-analysis. Overall, the risk of infection (Peto OR: 1.16, 95% confidence interval [CI]: 1.07-1.26, P < 0.001), serious infection (Peto OR: 1.65, 95% CI: 1.26-2.17, P < 0.001), upper respiratory tract infection (URTI) (Peto OR: 1.17, 95% CI: 1.04-1.32, P = 0.008), nasopharyngitis (Peto OR: 1.25, 95% CI: 1.10-1.42, P < 0.001), and Candida infection (Peto OR: 2.64, 95% CI: 1.48-4.71, P = 0.001) were increased in SpA patients treated with biologics compared with placebo. Sensitivity analysis based on biologics classes was conducted, and results demonstrated that compared with placebo, there was a higher risk of infection for tumor necrosis factor (TNF)-α inhibitors (Peto OR: 1.38, 95% CI: 1.13-1.68, P = 0.001) and interleukin (IL)-17 inhibitors (Peto OR: 1.55, 95% CI: 1.08-2.22, P = 0.018) in axial SpA, and for Janus kinase inhibitors in peripheral SpA (Peto OR: 1.39, 95% CI: 1.14-1.69, P = 0.001); higher risk of serious infection for IL-17 inhibitors in peripheral SpA (Peto OR: 3.46, 95% CI: 1.26-9.55, P = 0.016) and axial SpA (Peto OR: 2.01, 95% CI: 1.38-2.91, P < 0.001); higher risk of URTI for TNF-α inhibitors in axial SpA (Peto OR: 1.37, 95% CI: 1.05-1.78, P= 0.019), and for apremilast in peripheral SpA (Peto OR: 1.60, 95% CI: 1.08-2.36, P = 0.018); higher risk of nasopharyngitis for TNF-α inhibitors in axial SpA (Peto OR: 1.41, 95% CI: 1.05-1.90, P = 0.022) and peripheral SpA (Peto OR: 1.49, 95% CI: 1.09-2.05, P = 0.013), and for IL-17 inhibitors in axial SpA (Peto OR: 1.35, 95% CI: 1.01-1.82, P = 0.044); higher risk of herpes zoster for Janus kinase inhibitors in peripheral SpA (Peto OR: 2.18, 95% CI: 1.03-4.62, P = 0.043); higher risk of Candida infection for IL-17 inhibitors in peripheral SpA (Peto OR: 2.52, 95% CI: 1.31-4.84, P= 0.006).Conclusions:This meta-analysis shows that biological therapy in patients with SpA may increase the risk of infections, including serious infections, URTI, nasopharyngitis, and Candida infection, which should be paid attention to in our clinical practice.

简介：Thetwocompounds,2,2-dimethyl-4-S-(N,N-dimethyldithiocarbamato)-5-(1,2,4-triazol-l-yl)-propione(1)and2,2-dimethyl-4-S-(N,N-diethyldithiocarbamato)-5-(1,2,4-triazol-1-yl)-3-propione(2),werepreparedbyreactingN,N-dialkyldithiocarbamatesodiumwith2,2-dimethyl-4-bromo-5-(1,2,4-triazol-1-yl)-propione.Theirstructureswereidentifiedbyelementalanalysis,IRand^1HNMRspectroscopy.Thestructureof1hasbeendeterminedbyX-raysinglecrystalstructureanalysis.ItcrystallizesinmonoclinicsystemwithspacegroupP21/c,a=1.2315(3)nm,b=1.2057(2)nm,c=1.2532(3)nm,β=118.55(3)°,Z=4,V=1.6345(6)nm^3,Dc=1.221g/cm^3,μ=0.324mm^-1,F(000)=640,finalR1=0.0449.ThereisobviouspotentiallyweakC—H...Nintermolecularinteractioninthecrystal,whichstabilizesthecrystalstructure.Theresultofthebiologicaltestshowedthatthetwocompoundshavefungistasisandplantgrowthregulatingactivities.

简介：Acompetitiveenzyme-linkedimmunosorbentassay(ELISA)wasdevelopedtodetermineruscogenin(RUS)byusingthemonoclonalantibody(McAb).ThemonoclonalantibodyagainstRUS,secretedfromtheestablishedhybridomacelllines,wasidentifiedasbeingoftheIgG1isotype.TheMcAbexhibitedhighspecificitytoRUS,showingaveryslightcrossreactivitywithdiosgenin(15.7%),andnocross-reactivitytosarsasapogenin,diammoniumglycyrrhizinate,oleanolicacidandnotoginsenosideR1.TheestablishedELISA,atanIC50valueof157.55ng.mL-1andadetectionlimit(IC20)of20.57ng.mL-1,wascomparedwithHPLCanalyses,andagoodcorrelationbetweenELISAandHPLC-ELSDanalysesofRUSintheextractofRadixOphiopogoniswasobtained.TheexperimentaldataindicatedthattheELISAmethodexhibitsmoreadvantagesoverHPLC-ELSD,suchaslowdetectionlimit,highspecificity,lowbackground,andnorequirementforsamplepre-treatment,andismoresuitableforthedeterminationofnaturalcomponentsinChinesetraditionalmedicinesandinbiologicalsamplesforpharmacokineticstudies.

简介：TwoN-dichloroacetyloxazolidinesweresynthesizedwithasimple,mildandconvenientmethod.AllthecompoundswerecharacterizedbyIR,^1HNMRandelementalanalysis.Thepreliminarybiologicaltestshowedthatthecompoundsprotectedmaizeagainstinjurybysomeherbicidestosomeextent.

简介：AbstractAlthough the first-line rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone regimen (R-CHOP) substantially improved outcomes for patients with diffuse large B-cell lymphoma (DLBCL), 40% of the patients suffered from relapsed/refractory disease and had poor survival outcomes. The detailed mechanism underlying R-CHOP resistance has not been well defined. For this review, we conducted a thorough search for literature and clinical trials involving DLBCL resistance. We discussed DLBCL biology, epigenetics, and aberrant signaling of the B-cell receptor (BCR), phosphatidylinositol 3-kinase (PI3K)/Akt, nuclear factor kappa light chain enhancer of activated B-cells (NF-κB), and the Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathways as defining mechanisms of DLBCL heterogeneity and R-CHOP resistance. The cell of origin, double- or triple-hit lymphoma and double-protein-expression, clonal evolution, tumor microenvironment, and multi-drug resistance help to contextualize DLBCL resistance in an (epi)genetically and biologically comparative manner. With better understanding of the biological and molecular landscape of DLBCL, a more detailed classification system and tailored treatments will ideally become available to further improve the prognosis of DLBCL patients.

简介：部分地我，作者成功了联合光谱大气的模型(SAMIL_R42L9)在为大气的科学和地球物理的液体动力学的数字建模的国家重点实验室发展了，大气的物理的研究所，有陆地表面的中国科学院(LASG/IAP/CAS)当模特儿，Atmosphere-Vegetation-Interaction-Model(AVIM)并且分析了气候物理流动由R42_AVIM模仿了的基本状态和陆地表面。在这第二部分，我们进一步评估生物过程的模仿的结果，包括叶区域索引(LAI)，生物资源和网主要生产率(NPP)等等。结果显示R42_AVIM能模仿LAI的全球分发并且有好一致性，每月吝啬的LAI为气象学由马克斯普朗克常数研究所提供了。模仿的生物资源相当对应于植被分类。另外，模仿的年度吝啬的NPP有一致分布，数据由IGBP和MODIS提供了，并且在文学与工作作比较很好。联合模型将为关于在气候和生物圈之间的双向相互作用的研究为一个新实验工具提供的这口陆地空气，和全球陆上的生态系统碳周期。

简介：

简介：Objective:TostudythedifferencesandsimilaritiesoftheantisensedrugswithdifferentstructuresonthebiologicalfunctionsofK562cells.Methods:Cytotoxiceffectsweremeasuredbyuseofacellviabilityassay.FlowcytometricanalysisandagarosegelelectrophoresisofDNAfragmentationwerealsoperformed.Theexpressionlevelofproteinwasassayedbyimmunofluorescenceusingfluoresceisothiocyanatelabel.Results:PNAtargetingthecodingregionoftheBcl-2messengerRNAcouldeffectivelyinhibitK562cellviability,down-regulatethesynthesisoftheBcl-2proteinandincreasecellapoptosis.By72haftertheBcl-2antisensePNAtreatment,K562cellsshowedmorereductioninthelevelofBcl-2proteincomparedwithcellstreatedwiththeantisenseODN.Aftertreatmentwith10μmol/LofBcl-2antisensePNAorantisenseODNfor72h,apoptoticratesofK562cellswere13.15±1.13and11.72±1.12,respectively.Furthermore,therewassignificantdifferenceinthepercentageofapoptoticcellsbetweenantisensePNAgroupandantisenseODNgroup.Conclusion:TheresultssuggestthatantisensePNAtargetingthecodingregionofBcl-2mRNAhasbetterantisenseeffectsthantheantisenseoligonucleotidesoninducingapoptosisofK562cells.

简介：AbstractBipolar clavicular dislocation is rare, and therefore its management is contentious. With an increase of patient’s physical demand and a near-normal shoulder function, there has been a shift in the paradigm of its management from a conservative one to a stabilized one of anatomical open reduction. Proposed methods of fixation have also evolved with the advent of more biological fixation devices, which elude implant or fixation related complications. This case report highlights the salient features of this rare case and details the management options along with the benefits of biological anatomical repair and reconstruction.

简介：Purpose:Thisstudywastoinvestigatetheassociationbetweenulnarvariance(UV)andbiologicalandtrainingcharacteristics,handgrip,andwristpaininagroupof23Portugueseskeletallyimmaturemalegymnasts(aged11.22.5years).Methods:LeftandrightUVwasobtainedusingHafner'sprocedureandskeletalagewasdeterminedbytheTannereWhitehouse3-method.AnegativemeanvalueforUVmeasureswasobserved(2.4to3.6mm)withoutsignificantdifferenceswithincreasingage-category(p=0.09top=0.48).SignificantlowcorrelationswereobservedbetweensomeUVparametersandstature,fatpercentage,yearsoftraining,andlefthandgripstrength.Results:TengymnastsreportedwristpainwithgradualonsetandUVvalueswereverysimilarbetweenpainlessandpainfulwrists.Conclusion:ThefindingsofthisstudydonotdirectlysupportthethesisthatgymnasticstrainingandbiologicalvariablesorwristpainareassociatedwithUV.

简介：57个细菌从水取样从海洋的不同纬度和经度是镇定的南部的海洋(印度部门)被孤立。所有isolates能在4点成长吗？？

简介：我们在奇塔贡·希尔道在Khagarachari山区域的Aatmile从二个代表性的地点收集了土壤样品。这些地点之一在转移耕作和其它下面是邻近的13年的旧柚木种植园。两个地点在有寓言土壤的地文学的状况和一样的方面打的一样，它使我们能测量在土壤上转移耕作的效果微植物群。我们学习了土壤物理化学的性质和土壤微生物的生物化学、生物的性质。象真菌和细菌的人口一样的潮湿和有机物内容，两个在表面和表面下的土壤，显著地(p0.001)在不在转移耕作下面与土壤相比转移栽培土壤更低，即柚木种植园地点。在表面(010厘米)的最丰富的细菌并且表面下(1020厘米)分别地，当时，在转移耕作下面的土壤是Pseudomonasdiminuta和Shigella在柚木种植园的相应土壤层，占优势的微生物是杆菌firmus(010厘米)和Xanthomonas(1020厘米)。因为，微生物引起的人口差别不能被土壤质地差别解释组织上从二个地点的土壤的类似但是能在在转移耕作下面的土壤与显著地更低的潮湿和有机物内容有关。

简介：AbstractImmunotherapy that targets checkpoints, especially programmed cell death protein 1 and programmed cell death ligand 1, has revolutionized cancer therapy regimens. The overall response rate to mono-immunotherapy, however, is limited, emphasizing the need to potentiate the efficacy of these regimens. The functions of immune cells are modulated by multiple stimulatory and inhibitory molecules, including lymphocyte activation gene 3 (LAG-3). LAG-3 is co-expressed together with other inhibitory checkpoints and plays key roles in immune suppression. Increasing evidence, particularly in the last 5 years, has shown the potential of LAG-3 blockade in anti-tumor immunity. This review provides an update on the biological properties and clinical applications of LAG-3 in cancers.

简介：AbstractBackground:Concerns exist regarding the potential development of tuberculosis in patients with rheumatoid arthritis (RA) treated with biological and targeted drugs. We assessed systematically whether biological therapy increased the risk of tuberculosis in patients with RA by meta-analysis of randomized controlled trials (RCTs).Methods:A systematic literature search was conducted in PubMed, Embase, the Cochrane Library, and China Biology Medicine disc for RCTs evaluating biological therapy in patients with RA from inception through August 2021. Traditional meta-analysis and network meta-analysis were performed to compare the risk of tuberculosis for each biologics class in patients with RA. Peto odds ratio (Peto OR) and its 95% confidence interval (CI) were calculated as the primary effect measure.Results:In total, 39 studies with 20,354 patients were included in this meta-analysis, and 82 patients developed tuberculosis. The risk of tuberculosis was increased in patients treated with biologics compared with non-biologics (Peto OR: 3.86, 95% CI: 2.36-6.32, P < 0.001). Also, tumor necrosis factor-α (TNF-α) inhibitors had a higher probability of developing tuberculosis than placebo (Peto OR: 3.98, 95% CI: 2.30-6.88, P < 0.001). However, network meta-analysis demonstrated that there was no significant difference in the risk of tuberculosis for each biologics class in patients with RA. Noticeably, tuberculosis was significantly more common in patients treated with a high dose compared with patients receiving a low dose of tofacitinib (Peto OR: 7.39, 95% CI: 2.00-27.31, P = 0.003).Conclusion:This meta-analysis demonstrates the evidence of an elevated risk of tuberculosis in patients with RA treated with TNF-α inhibitors, and a dose-dependent elevated risk of tuberculosis in patients treated with tofacitinib.

简介：Havingbeenpassedfor160generations,acelllinedesignatedasH22-F25/LwasestablishedfromamurinetumorlymphaticmetastatlcmodelH22-F25whichhadbeensetupinourcollege.Thecelllinewasinsuspensionculturewitharapidproliferationandstablegrowth.Thepeaktuneofcelldivisionandproliferationwas48and96hoursafterculture.Inaweek,thecellnumberwasIncreasedby25tunes.H22-F25/Lstillkeepsthefeaturesofapoorlydifferentiatedcancer.Itstumorinducingrate(invivo)was100%in615mice.Lymphnodemetastasisratewas50%andpulmonarymetastasisrate10%.H22-F25/LIsapopulationofheterogenetlctumorcellsIncluding2stemcelllines(themodelnumberofchromosomesbeing43in40%tumorcellsand86in32%)andsomesidelines.ThecommonmarkerchromosomesM1,M2,M3andM4werepresentinallstemandsidelines.

简介：Pt(Ⅱ)andPd(Ⅱ)complexeswith2',3',4',5,7-pentahydroxy-flavoneweresynthesizedandcharacterizedbyelementalanalysis,molarconductance,IR,1HNMR,TG-DTA,UV-Visspectroscopictechniques,andfluorescenceanalysis.Thescavengingeffectonthesuperoxideradical(O-2)andtheinhibitoryeffectonlipidperoxideswerealsoinvestigated.Boththeligandandthecomplexesexhibitscavengingeffectonsuperoxideradicals,andtheeffectofthecomplexesisgreaterthanthatoftheligand.ThePt(Ⅱ)complexexhibitsthestrongestscavengingefficiency.BothPt(Ⅱ)andPd(Ⅱ)complexeshavetheinhibitoryeffectonlipidperoxides,andtheeffectofthecomplexesisgreaterthanthatoftheligand,butthePt(Ⅱ)complexhasahigheffectofpromotinglipidperoxides.